Ryman Healthcare Ltd
RYM: XNZE (NZL)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
NZD 1.80 | Trznm | Tggsmczbt |
Ryman Continues to Ride on Momentum, NZD 13.00 FVE Unchanged
Transition of our coverage to a new analyst and an acceleration in fiscal 2019 build rate prompts a revision in our development and margin forecasts for narrow-moat Ryman Healthcare, but our fair value estimate of NZD 13.00 remains intact.